MedTrace Logo

Lipid Metabolism in COVID-19 Severe Pneumonia Compared With Severe Pneumonia Caused by Other Pathogen

NCT04435223 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 62

Last updated 2026-02-02

No results posted yet for this study

Summary

SARS-COV 2 infection might be responsible for sever pneumonia. Obesity seems to be a risk factor for severe SARS-COV 2 pneumonia. Lipid metabolism alteration are described with both obesity and sepsis. The aim of the present study was to describe association between lipid metabolism, obesity, sepsis inflammation and clinical outcome in COVID-19 patient with severe pneumonia compared with severe pneumonia caused by other pathogenes.

Conditions

  • COVID-19 Severe Pneumonia
  • Severe Pneumonia Due to Other Pathogene

Interventions

BIOLOGICAL

biological assays in particular on the lipid metabolism

bioassays carried out on samples already collected and conserved

Sponsors & Collaborators

  • Centre Hospitalier Universitaire Dijon

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-07
Primary Completion
2020-05-07
Completion
2020-05-07

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04435223 on ClinicalTrials.gov